Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.

Events

Event When
Credit Suisse London Healthcare Conference

February 28 - March 1, 2023

Barclay's Healthcare Conference

March 14-15, 2023

Jefferies 3rd Pan European Mid Cap Conference

March 28-30, 2023

First Quarter 2023 Financial Results reporting*

April 25, 2023

Annual General Meeting of Shareholders

May 4, 2023

Bank of America Healthcare Conference

May 9-11, 2023

Jefferies Healthcare Conference

June 7-9, 2023

Goldman Sachs Global Healthcare Conference

June 12-15, 2023

Citi European Healthcare Conference

June 20-21, 2023

J.P. Morgan European Healthcare Conference

June 22, 2023

Stifel European Healthcare Summit 

June 29-30, 2023

Half-Year 2023 Financial Results reporting*

July 25, 2023

Citi BioPharma Conference

September 6-7, 2023

Morgan Stanley Global Healthcare Conference

September 11-14, 2023

Bank of America Global Healthcare Conference

September 13-14, 2023

Baader Investment Conference

September 18-22, 2023

9-month 2023 Financial Results reporting*

October 24, 2023

*We will be in a silent period for 10 days ahead of the financial reporting.

Stay informed

Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.

Stay informed

Social Media

Idorsia is active on social media – follow our channels to get a more personal view on the company.

Social Media

Media center

Idorsia provides images, fact sheets and B-roll to download or support you with your article.

Media center

Contact

Contact

Andrew C. Weiss

Senior Vice President, Head of Investor Relations and Corporate Communications

Media Relations

Resources in German

Als schweizerisches Unternehmen stellen wir interessierten Personen auf dieser Seite wesentliche Informationen über unser Unternehmen in deutscher Sprache zur Verfügung.